Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis

Cell

Volumn 86, Issue 2, 1996, Pages 189-199

  Santana, Pino ^a   Peña, Louis A ^a   Haimovitz Friedman, Adriana ^a   Martin, Seamus ^c   Green, Douglas ^c   McLoughlin, Maureen ^a   Cordon Cardo, Carlos ^a   Schuchman, Edward H ^b   Fuks, Zvi ^a   Kolesnick, Richard ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; COMPLEMENTARY DNA; SPHINGOMYELIN PHOSPHODIESTERASE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; DIAGNOSIS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IONIZING RADIATION; LYMPHOBLAST; MOUSE; NIEMANN PICK DISEASE; NONHUMAN; PRIORITY JOURNAL; RADIATION HAZARD; SECOND MESSENGER; TRANSACTIVATION;

EID: 16044364385     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80091-4     Document Type: Article

References (68)

1. Allan, D.J. (1992). Radiation-induced apoptosis: its role in a MADCaT (mitosis-apoptosis-differentiation-calcium toxicity) scheme of cytotoxicity mechanisms. Int. J. Radiat. Biol. 62, 145-152.
2. Anderson, M.A., and Gusella, J.F. (1984). Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines. In Vitro 20, 856-858.
3. Bose, R., Verheij, M., Haimovitz-Friedman, A., Scotto, A., Fuks, Z., and Kolesnick, R.N. (1995). Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82, 405-414.
4. Boucher, L.-M., Wiegmann, K., Futterer, A., Pfeffer, K., Machleidt, T., Schutze, S., Mak, T.W., and Kronke, M. (1995). CD28 signals through acidic sphingomyelinase. J. Exp. Med. 181, 2059-2068.
5. Bradford, J.S. (1991). Sublethal damage, potentially lethal damage, and chromosomal aberrations in mammalian cells exposed to ionizing radiation. Int. J. Radiat. Oncol. Biol. Phys. 21, 1457-1469.
6. Brady, R.O., Kanfer, J.N., Mock, M.B., and Fredrickson, D.S. (1966). The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick disease. Proc. Natl. Acad. Sci. USA 55, 366-369.
7. Chen, J.P.S., Toribara, T.Y., and Warner, H. (1956). Microdetermination of phosphorus. Anal. Chem. 28, 1756-1758.
8. Cifone, M.G., De Maria, R., Roncaioli, P., Rippo, M.R., Azuma, M., Lanier, L.L., Santoni, A., and Testi, R. (1993). Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med. 177, 1547-1552.
9. Cifone, M.G., Roncaioli, P., De Maria, R., Camarda, G., Santoni, A., Ruberti, G., and Testi, R. (1995). Multiple pathways originate at the Fas/APO-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J. 14, 5859-5868.
10. Coleman, C.N. (1993). Beneficial liaisons: radiobiology meets cellular and molecular biology. Radiother. Oncol. 28, 1-15.
11. Dewey, W.C., Miller, H.H., and Leeper, D.B. (1971). Chromosomal aberrations and mortality of x-irradiated mammalian cells: emphasis on repair. Proc. Natl. Acad. Sci. USA 68, 667-671.
12. Dewey, W.C., Ling, C.C., and Meyn, R.E. (1995). Radiation-induced apoptosis: relevance to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 33, 781-796.
13. Dobrowsky, R.T., and Hannun, Y.A. (1992). Ceramide stimulates a cytosolic protein phosphatase. J. Biol. Chem. 267, 5048-5051.
14. Dobrowsky, R.T., and Hannun, Y.A. (1993). Ceramide-activated protein phosphatase: partial purification and relationship to protein phosphatase 2A. Adv. Lipid Res. 25, 91-104.
15. Dressler, K.A., and Kolesnick, R.N. (1990). Ceramide 1-phosphate, a novel phospholipid in human leukemia (HL-60) cells synthesis via ceramide from sphingomyelin. J. Biol. Chem. 256, 14917-14921.
16. Dressler, K.A., Mathias, S., and Kolesnick, R.N. (1992). Tumor necrosis factor-α activates the sphingomyelin signal transduction pathway in a cell-free system. Science 255, 1715-1718.
17. Fuks, Z., Alfieri, A., Haimovitz-Friedman, A., Seddon, A., and Cordon-Cardo, C. (1995). Intravenous basic fibroblast growth factor protects the lung but not mediastinal organs against radiation-induced apoptosis in vivo. Cancer J. 1, 62-72.
18. Gulbins, E., Coggeshall, K.M., Langlet, C., Baier, G., Bonnefoy-Berard, N., Burn, P., Wittinghofer, A., Katzav, S., and Altman, A. (1994). Activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein. Mol. Cell. Biol. 14, 906-913.
19. Gulbins, E., Bissonnette, R., Mahboubi, A., Martin, S., Nishioka, W., Brunner, T., Baier, G., Baier-Bitterlich, G., Byrd, C., Lang, F., Kolesnick, R., Altman, A., and Green, D. (1995). FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 2, 341-351.
20. Haimovitz-Friedman, A., Kan, C., Ehleiter, D., Persaud, R., McLoughlin, M., Fuks, Z., and Kolesnick, R.N. (1994). Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med. 180, 525-535.
21. Hall, E.J. (1994). Molecular biology in radiation therapy: the potential impact of recombinant technology on clinical practice. Int. J. Radiat. Oncol. Biol. Phys. 30, 1919-1928.
22. Hannun, Y.A., and Obeid, L.M. (1995). Ceramide: an intracellular signal for apoptosis. Trends Biochem. Sci. 20, 73-77.
23. Harnden, D.G. (1994). The nature of ataxia-telangiectasia: problems and perspectives. Int. J. Radiat. Biol. 66, 9-13.
24. Horinouchi, K., Erlich, S., Perl, D.P., Ferlinz, K., Bisgaier, C.L., Sandhoff, K., Desnick, R.J., Stewart, C.L., and Schuchman, E.H. (1995). Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nature Genet. 10, 288-293.
25. Hurwitz, C., and Tolmach, J.T. (1969). Time-lapse cinemicrographic studies of x-irradiated HeLa S3 cells. Biophys. J. 6, 607-633.
26. Jarvis, W.D., Kolesnick, R.N., Fornari, F.A., Traylor, R.S., Gewirtz, D.A., and Grant, S. (1994). Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc. Natl. Acad. Sci. USA 91, 73-77.
27. Jarvis, W.D., Grant, S., and Kolesnick, R.N. (1995). Ceramide and the induction of apoptosis. Clin. Cancer Res. 2, 1-6.
28. Kemp, C.J., Donehower, L.A., Bradley, A., and Balmain, A. (1993). Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 74, 813-822.
29. Kolesnick, R.N. (1991). Sphingomyelin and derivatives as cellular signals. Prog. Lipid Res. 30, 1-38.
30. Kuida, K., Lippke, J.A., Ku, G., Harding, M.W., Livingston, D.J., Su, M.S.-S., and Flavell, R.A. (1995). Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267, 2000-2003.
31. Levran, O., Desnick, R.J., and Schuchman, E.H. (1991a). Niemann-Pick type B disease: identification of a single codon deletion in the acid sphingomyelinase gene and genotype/phenotype correlations in type A and B patients. J. Clin. Invest. 88, 806-810.
32. Levran, O., Desnick, R.J., and Schuchman, E.H. (1991b). Niemann-Pick disease: afrequent missense mutation in the acid sphingomyelinase gene of Ashkenazi Jewish type A and B patients. Proc. Natl. Acad. Sci. USA 88, 3748-3752.
33. Liu, J., Mathias, S., Yang, Z., and Kolesnick, R.N. (1994). Renaturation and TNFα stimulation of a 97 kDa ceramide-activated protein kinase. J. Biol. Chem. 269, 3047-3052.
34. Liu, P., and Anderson, R.G.W. (1995). Compartmentalized production of ceramide at the cell surface. J. Biol. Chem. 270, 27179-27185.
35. Lowe, S.W. (1995). Cancer therapy and p53. Curr. Opin. Oncol. 7, 547-553.
36. Lowe, S.W., Ruley, H.E., Jacks, T., and Housman, D.E. (1993). p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957-967.
37. Lozano, J., Berra, E., Municio, M.M., Diaz-Meco, M.T., Dominguez, I., Sanz, L., and Moscat, J. (1994). Protein kinase C ζ isoform is critical for κB-dependent promoter activation by sphingomyelinase. J. Biol. Chem. 269, 19200-19202.
38. Maruyama, E.N., and Arima, M. (1989). Purification and characterization of neutral and acid sphingomyelinases from rat brain. J. Neurochem. 52, 611-618.
39. Mathias, S., Younes, A., Kan, C.-C., Orlow, I., Joseph, C., and Kolesnick, R.N. (1993). Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β. Science 259, 519-522.
40. McMillan, T.J. (1992). Residual DNA damage: what is left over and how does this determine cell fate. Eur. J. Cancer 28, 267-269.
41. Merrill, J.-A.H., Wang, E., Mullins, R.E., Jamison, W.C.L, Nimkar, S., and Liotta, D. (1988). Quantitation of free sphingosine in liver by high performance liquid chromatography. Anal. Biochem. 171, 373-381.
42. Muller, G., Ayoub, M., Storz, P., Rennecke, J., Fabbro, D., and Pfizenmaier, K. (1995). PKCζ is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14, 1961-1969.
43. Obeid, L.M., Linardic, C.M., Karolak, L.A., and Hannun, Y.A. (1993). Programmed cell death induced by ceramide. Science 259, 1769-1771.
44. 3 in HL-60cells: role in cell differentiation. J. Biol. Chem. 264, 19076-19080.
45. 3-induced HL-60 cell differentiation. J. Biol. Chem. 269, 4070-4077.
46. Olivera, A., Buckley, N.E., and Spiegel, S. (1992). Sphingomyelinase and cell-permeable ceramide analogs stimulate cellular proliferation in quiescent Swiss 3T3 fibroblasts. J. Biol. Chem. 267, 26121 -26127.
47. Otterbach, B., and Stoffel, W. (1995). Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease). Cell 81, 1053-1061.
48. Radford, I.R. (1986). Evidence for a general relationship between the induced level of DNA double-strand breakage and cell-killing after x-irradiation of mammalian cells. Int. J. Radiat. Biol. 49, 611-620.
49. Rao, B.G., and Spence, M.W. (1976). Sphingomyelinase activity at pH 7.4 in human brain and a comparison to activity at pH 5.0. J. Lipid Res. 17, 506-515.
50. Schneider, P.B., and Kennedy, E.P. (1967). Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease. J. Lipid Res. 8, 202-209.
51. Schuchman, E.H., Suchi, M., Takahahi, T., Sandhoff, K., and Desnick, R.J. (1991). Human acid sphingomyelinase: isolation, nucleotide sequence, and expression of the full-length and alternatively spliced cDNAs. J. Biol. Chem. 266, 8531-8539.
52. Schuchman, E.H., Levran, O., and Desnick, R.J. (1992). Structural organization and complete nucleotide sequence of the gene encoding human acid sphingomyelinase. Genomics 12, 197-205.
53. Seki, H., Kanegane, H., Iwai, K., Konno, A., Ohta, K., Yachie, A., Taniguchi, N., and Miyawaki, T. (1994). Ionizing radiation induces apoptotic cell death in human TcR-γ/δ+ T and natural killer cells without detectable p53 protein. Eur. J. Immunol. 24, 2914-2917.
54. Steele, G.G., McMillan, T.J., and Peacock, J.H. (1989). The picture has changed in the 1980s. Int. J. Radiat. Biol. 56, 525-537.
55. Strasser, A., Harris, A.W., Jacks, T., and Cory, S. (1994). DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79, 329-339.
56. Suchi, M., Dinur, T., Desnick, R., Gatt, S., Pereira, L., Gilboa, E., and Schuchman, E. (1992). Retroviral-mediated transfer of the human acid sphingomyelinase cDNA: correction of the metabolic defect in cultured Niemann-Pick disease cells. Proc. Natl. Acad. Sci. USA 89, 3227-3231.
57. Tepper, C.G., Jayadev, S., Liu, B., Bielawska, A., Wolff, R., Yonehara, S., Hannun, Y.A., and Seldin M.F. (1995). Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc. Natl. Acad. Sci. USA 92, 8443-8447.
58. Thompson, L.H. (1991). Properties and applications of human DNA repair genes. Mutat. Res. 247, 213-219.
59. Thompson, L.H., and Suit, H.D. (1969). Proliferation kinetics of x-irradiated mouse L cells studied with time-lapse photography. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 15, 347-362.
60. Van Veldhoven, P., Bishop, W.R., and Bell, R.M. (1989). Enzymatic quantitation of sphingosine in the picomole range in cultured cells. Anal. Biochem 183, 177-189.
61. Verheij, M., Bose, R., Lin, X.-H., Yao, B., Grant, S., Birrer, M.J., Szabo, E., Zon, L.I., Kyriakis, J.M., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R.N. (1996). Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380, 75-79.
62. Wang, Z.-Q., Auer, B., Stingl, L., Berghammer, H., Haidacher, D., Schweiger, M., and Wagner, E.F. (1995). Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev. 9, 509-520.
63. Ward, J.F. (1994). The complexity of DNA damage: relevance to biological consequences. Int. J. Radiat. Biol. 66, 427-432.
64. Wiegmann, K., Schutze, S., Machleidt, T., Witte, D., and Kronke, M. (1994). Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78, 1005-1015.
65. Yao, B., Zhang, Y., Delikat, S., Basu, S., and Kolesnick, R. (1995). Ceramide-activated protein kinase is a Raf kinase. Nature 378, 307-310.
66. Yedger, S., and Gatt, S. (1976). Effect of Triton X-100 on the hydrolysis of sphingomyelin by sphingomyelinase of rat brain. Biochemistry 15, 2570-2573.
67. Yeyati, P.L., Agmon, V., Fillat, C., Dinor, T., Dagan, A., Desnick, R.J., Gatt, S., and Schuchman, E.H. (1995). Fluorescence-based selection of retrovirally transduced cells in the absence of a gene marker: direct selection of transduced type B Niemann-Pick disease cells and evidence for bystander correction. Hum. Gene Ther. 6, 975-983.
68. Zhang, Y., and Kolesnick, R.N. (1995). Signaling through the sphingomyelin pathway. Endocrinology 136, 4157-4160.